Calidi Biotherapeutics
CLDI
CLDI
24 hedge funds and large institutions have $39.6M invested in Calidi Biotherapeutics in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Holders
24
Holding in Top 10
–
Calls
$616K
Puts
–
Top Buyers
| 1 | +$5.08M | |
| 2 | +$3.22M | |
| 3 | +$2.61M | |
| 4 |
EC
Elequin Capital
New York
|
+$1.73M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$971K |
Top Sellers
| 1 | -$9.47M | |
| 2 | -$1.47M | |
| 3 | -$893K | |
| 4 |
VF
Virtu Financial
New York
|
-$673K |
| 5 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$369K |